Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
- the Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Lady Cilento Children'S Hospital
South Brisbane, Queensland, Australia
- Royal Children'S Hospital, Melbourne
Parkville, Victoria, Australia
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Sainte-Justine University Hospital Center
Montréal, Québec, Canada
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Orange County
Orange, California, United States
- Ucsf School of Medicine
San Francisco, California, United States
- the Children'S Hospital, University of Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Miami
Miami, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
- Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Sidney Kimmel Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- National Cancer Institute, Pediatric Oncology Branch
Bethesda, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Cs Mott Children'S Hospital, Ann Arbor
Ann Arbor, Michigan, United States
- Children'S Hospitals and Clinics of Minnesota
Minneapolis, Minnesota, United States
- Children'S Hospital New York-Presbyterian
New York, New York, United States
- Levine Children'S Hospital
Charlotte, North Carolina, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Rainbow Babies & Children'S Hospital
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Monroe Carell Jr. Children'S Hospital at Vanderbilt
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Texas Children'S Cancer Center, Baylor
Houston, Texas, United States
- Primary Children'S Hospital
Salt Lake City, Utah, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2017
- Primary completion
- 29 Jul 2022
- Completion
- 31 Dec 2024
- Last update posted
- 22 Oct 2025
- Registered enrollment
- 29
- Registry id
- NCT02879643
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.